Drug & medication recalls Moderate risk

Nivagen Pharmaceuticals Inc recalls Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle, Manufactured for: Nivagen Pharmaceuticals, I…

Recall date
September 24, 2024
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0001-2025
FDA classification
Class II
Brand / firm
Nivagen Pharmaceuticals Inc
Sold / distributed
Nationwide within the U.S

Why it was recalled

Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle, Manufactured for: Nivagen Pharmaceuticals, Inc. Sacramento, CA 95827, USA, Manufactured by: Umedica Laboratories Pvt Ltd., Vapi Gujarat 396195, India, NDC: 75834-257-01.

Get recall alerts

Free email alert whenever Nivagen Pharmaceuticals Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Nivagen Pharmaceuticals Inc